Main Session
Sep 28
PQA 04 - Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Functional Radiation Medicine, Hematologic Malignancies, Palliative Care, and International/Global Oncology

2856 - DTI-Based Trigeminal Response Index Predicts 5-Year Radiosurgery Durability

03:00pm - 04:00pm ET
Poster Hall - Exhibit Hall A
Screen: 11
POSTER

Presenter(s)

Vangipuram Sai Shreya, MBBS - Sri Rama Chandra Medical College, Chennai, Tamil Nadu

V. Sai Shreya1, V. Shankar2, H. S. Vangipuram3, S. Ghosh4, S. Cholayil5, and D. Arjundas6; 1Dept of General Medicine, Sri Rama Chandra Medical College, Porur, Chennai, India, 2Division of Radiosurgery, Apollo Cancer Centers, Chennai, India, 3Department of Undergradute Education, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India, 4Dept. of Neurosurgery, Apollo Proton Cancer Center, Chennai, India, 5Apollo Cancer Centers, Chennai, India, 6Chief Neurologist, Mercury Hospital, Chennai, India

Purpose/Objective(s): Outcome prediction after stereotactic radiosurgery (SRS) for trigeminal neuralgia (TN) remains imprecise. Conventional predictors — including BNI class, neurovascular contact, and dose parameters — lack biological specificity and fail to capture intrinsic nerve pathology. Diffusion-tensor imaging (DTI) enables detection of subtle microstructural injury. To translate these multidimensional metrics into a clinically actionable biomarker, we developed the Trigeminal Response Index (TN-RI) — a composite DTI-based score reflecting demyelination, axonal imbalance, and diffusional heterogeneity.

Materials/Methods: Twenty patients with classical TN underwent pre-treatment DTI followed by CyberKnife SRS. TN-RI was defined as:

TN-RI = (1 – FA) + RD + MD + (1 – AD_norm)

where AD_norm = AD(affected)/AD(contralateral) to minimize inter-subject variability in axonal diffusivity.

Patients were stratified into minimal/mixed (<2.0), moderate (2.0–2.5), and severe disruption (>2.5). Clinical outcomes were assessed at 12 months and longitudinally over a median 5-year follow-up. Associations between TN-RI and meaningful pain relief (BNI I–IIIb) were evaluated using Spearman correlation, logistic regression, and ROC analysis. Optimal thresholds were identified using Youden’s J statistic. Continuous variables were compared using Mann–Whitney U testing. FA–RD–MD heat-map modeling was performed to visualize the spectrum of microstructural injury.

Results: TN-RI demonstrated strong predictive performance at both early and long-term follow-up. Patients with TN-RI >2.5 achieved high rates of durable pain relief (~90%), sustained through 5 years. Intermediate outcomes were observed in the 2.0–2.5 range, while TN-RI <2.0 was associated with significantly reduced long-term durability (~60%) and correlated with minimal or mixed tractographic pathology. Logistic regression confirmed TN-RI as an independent predictor of favorable outcome. ROC analysis showed high discriminative accuracy. Heat-map modeling revealed a continuous biological gradient consistent with progressive microstructural compromise.

Conclusion: The Trigeminal Response Index provides a biologically grounded, quantitative measure of trigeminal nerve injury and reliably predicts both early and 5-year SRS outcomes. By integrating FA, RD, MD, and normalized AD into a single composite metric, TN-RI offers clearer clinical stratification than any individual DTI parameter currently used. TN-RI represents a promising biomarker for patient selection, treatment counseling, and mechanistic modeling in functional radiosurgery. Prospective multicenter validation is strongly warranted and underway.